市場調査レポート

商品コード

1618287

バイオ分析検査サービス市場の評価：検査タイプ・分子・用途・エンドユーザー・地域別の機会および予測 (2018-2032年)

Bioanalytical Testing Services Market Assessment, By Test Type, By Molecule, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2024年12月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 234 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 648,270円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 821,142円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,181,292円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオ分析検査サービスの市場規模は、2024年の40億4,000万米ドルから、予測期間中は10.69%のCAGRで推移し、2032年には91億米ドルの規模に成長すると予測されています。

研究開発費の増加、臨床試験の増加、生物製剤とバイオシミラーの需要が、バイオ分析検査サービスの市場成長を増大させています。このことは専門的な検査サービスへの需要を高め、アウトソーシングの動向を強化しています。そのため、技術の進歩が進み、今後数年間の強力な市場成長環境を生み出される見通しです。

糖尿病、癌、心血管障害などの慢性疾患の増加は、バイオ分析検査サービスへのニーズを加速させています。WHOによると、非伝染性疾患は世界の年間死亡者数の74%を占めています。このような負担の増加は、高度な医薬品開発と精密医療の必要性を要求しており、これらにおいてはバイオ分析検査が非常に重要です。このようなサービスは、適切かつ正確な治療効果と安全性の評価を提供し、医薬品のイノベーションと、世界中で高まるヘルスケア需要を満たす規制遵守に貢献します。

また、CROは、最先端のバイオ分析ラボの開設や戦略的パートナーシップにより、世界的な展開を拡させています。これらの活動は、提供するサービスを強化し、医薬品開発プロセスを合理化し、これらのサービスが各地域の規制に準拠することを保証します。このような重点的な拡大により、地域に特化した専門的なバイオ分析検査の需要が増加し、新たな成長機会が生まれています。

当レポートでは、世界のバイオ分析検査サービスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

上位5社の競合マトリックス
上位5社のSWOT分析
上位10社の情勢
- WuXi AppTec Co., Ltd.
- Eurofins Scientific SE
- Charles River Laboratories International, Inc.
- ICON Plc
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- SGS Societe Generale de Surveillance SA
- Intertek Group plc
- Frontage Laboratories, Inc.
- BioAgilytix Labs, LLC

第22章戦略的提言

第23章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 3. Global Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 4. Global Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 5. Global Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 6. Global Bioanalytical Testing Services Market Share (%), By Region, 2018-2032F
Figure 7. North America Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 8. North America Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 9. North America Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 10. North America Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 11. North America Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 12. North America Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 13. United States Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 14. United States Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 15. United States Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 16. United States Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 17. United States Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 18. Canada Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 19. Canada Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 20. Canada Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 21. Canada Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 22. Canada Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 23. Mexico Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 24. Mexico Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 25. Mexico Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 26. Mexico Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 27. Mexico Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 28. Europe Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 29. Europe Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 30. Europe Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 31. Europe Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 32. Europe Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 33. Europe Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 34. Germany Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 35. Germany Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 36. Germany Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 37. Germany Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 38. Germany Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 39. France Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 40. France Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 41. France Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 42. France Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 43. France Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 44. Italy Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 45. Italy Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 46. Italy Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 47. Italy Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 48. Italy Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 49. United Kingdom Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 50. United Kingdom Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 51. United Kingdom Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 52. United Kingdom Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 53. United Kingdom Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 54. Russia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 55. Russia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 56. Russia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 57. Russia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 58. Russia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 59. Netherlands Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 60. Netherlands Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 61. Netherlands Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 62. Netherlands Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 63. Netherlands Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 64. Spain Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 65. Spain Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 66. Spain Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 67. Spain Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 68. Spain Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 69. Turkey Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 70. Turkey Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 71. Turkey Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 72. Turkey Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 73. Turkey Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 74. Poland Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 75. Poland Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 76. Poland Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 77. Poland Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 78. Poland Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 79. South America Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 80. South America Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 81. South America Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 82. South America Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 83. South America Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 84. South America Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 85. Brazil Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 86. Brazil Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 87. Brazil Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 88. Brazil Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 89. Brazil Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 90. Argentina Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 91. Argentina Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 92. Argentina Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 93. Argentina Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 94. Argentina Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 95. Asia-Pacific Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 96. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 97. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 98. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 99. Asia-Pacific Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 100. Asia-Pacific Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 101. India Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 102. India Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 103. India Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 104. India Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 105. India Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 106. China Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 107. China Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 108. China Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 109. China Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 110. China Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 111. Japan Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 112. Japan Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 113. Japan Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 114. Japan Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 115. Japan Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 116. Australia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 117. Australia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 118. Australia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 119. Australia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 120. Australia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 121. Vietnam Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 122. Vietnam Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 123. Vietnam Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 124. Vietnam Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 125. Vietnam Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 126. South Korea Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 127. South Korea Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 128. South Korea Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 129. South Korea Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 130. South Korea Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 131. Indonesia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 132. Indonesia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 133. Indonesia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 134. Indonesia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 135. Indonesia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 136. Philippines Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 137. Philippines Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 138. Philippines Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 139. Philippines Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 140. Philippines Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 141. Middle East & Africa Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 142. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 143. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 144. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 145. Middle East & Africa Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 146. Middle East & Africa Bioanalytical Testing Services Market Share (%), By Country, 2018-2032F
Figure 147. Saudi Arabia Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 148. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 149. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 150. Saudi Arabia Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 151. Saudi Arabia Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 152. UAE Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 153. UAE Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 154. UAE Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 155. UAE Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 156. UAE Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 157. South Africa Bioanalytical Testing Services Market, By Value, In USD Billion, 2018-2032F
Figure 158. South Africa Bioanalytical Testing Services Market Share (%), By Test Type, 2018-2032F
Figure 159. South Africa Bioanalytical Testing Services Market Share (%), By Molecule, 2018-2032F
Figure 160. South Africa Bioanalytical Testing Services Market Share (%), By Application, 2018-2032F
Figure 161. South Africa Bioanalytical Testing Services Market Share (%), By End-user, 2018-2032F
Figure 162. By Test Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 163. By Molecule Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Product Code: MX12437

Global bioanalytical testing services market is projected to witness a CAGR of 10.69% during the forecast period 2025-2032, growing from USD 4.04 billion in 2024 to USD 9.10 billion in 2032. Growing R&D expenditure, rise in clinical trials, and demand for biologics and biosimilars augment the market's growth for bioanalytical testing services. This drives the demand for specialty testing services and enhances the trend of outsourcing; therefore, it improves technological advancement, which can collectively generate a strong market growth environment in the following years.

The rising cases of chronic diseases like diabetes, cancer, and cardiovascular disorders fuel the requirement for bioanalytical testing services. As per WHO, non-communicable diseases account for 74% of all global deaths annually. This increased burden demands a requirement for advanced drug development and precision medicine, wherein bioanalytical testing would be of immense importance. Such services provide proper and accurate therapeutic efficacy and safety assessment, thereby contributing to innovation in pharmaceuticals and regulatory compliance that satisfies increased healthcare demands around the globe.

Furthermore, CROs are expanding their global reach by opening state-of-the-art bioanalytical labs and strategic partnerships. These activities enhance the services offered, streamline drug development processes, and ensure that these services comply with regional regulations. This focused expansion unlocks new growth opportunities as the demand for localized and specialized bioanalytical testing increases. In August 2024, BioAgilytix Labs, LLC, recently opened the expanded 360biolabs laboratory in Melbourne, Australia. This cutting-edge facility provides a broad range of bioanalytical services such as LC-MS/MS, molecular testing, biomarker analysis, flow cytometry, large molecule PK and immunogenicity, virology, and central lab services, all performed in a quality-assured environment. This expansion supports global pharmaceutical and biotech clients, driving significant growth opportunities in the market.

Increasing R&D Expenditure Boosts Market Demand

Increasing R&D spending is also propelling the demand for bioanalytical testing in the market. As pharmaceutical companies invest more in R&D, clinical trials and drug development are rising, demanding more comprehensive bioanalytical testing services. Furthermore, pharmaceuticals' improvement and acceleration of R&D manufacturing units to enhance efficiency and make drug development more streamlined involves implementing advanced technologies and automation, for which specialized bioanalytical testing is required to ensure quality and safety. This concern about biologics and biosimilars also leads to more compatibility studies, stability testing, and protein analysis, further driving the bioanalytical testing market. In November 2024, AstraZeneca PLC made a USD 3.5 billion investment to accelerate R&D and manufacturing in the U.S. This expansion includes a new R&D center in Massachusetts and a next-gen biologics facility in Maryland. These improvements boost the development of leading-edge therapies and drive considerable growth opportunities in the market. With higher R&D investment comes greater demand for all-inclusive bioanalytical services for new pharmaceutical development and approval.

Rising Number of Clinical Trials Support Market Expansion

The rise in clinical trials has greatly propelled the growth of the bioanalytical testing services market. The volume of biological samples is increasing, and the complexity of the trials involving biologics and personalized medicines require advanced bioanalytical methods because of their tailored treatment approaches and complex molecular structures. Therefore, the demand for bioanalytical testing increases. Moreover, outsourcing bioanalytical testing, which focuses on biopharmaceuticals, including gene therapies and biosimilars, strengthens the market by improving efficiency and boosting investment in advanced technologies by pharmaceutical companies. Additionally, various collaborations ensure comprehensive clinical trial services in several companies to ease all drug development processes. All these collaborations positively influence the market through data accuracy, regulation compliance, and acceleration of new pharmaceutical approvals for its growth. In March 2024, EPNextS, Inc. and Frontage Laboratories, Inc. collaborated to improve early-phase clinical trials in Japan. This collaboration is meant to overcome the delay in drug availability due to strict regulations and complicated procedures. Combining their expertise, they are trying to streamline drug development and enhance market growth opportunities through improved access to innovative therapies.

Pharmaceuticals and Biopharmaceutical Companies Account for Significant Share of the Market

The pharmaceutical and biopharmaceutical firms are the most prominent end-users in this market for bioanalytical testing services, focusing on developing drugs and, hence, for severe stringent regulations. Such companies rely on bioanalytical testing for early-phase development, pharmacokinetics, and clinical laboratory testing. This has been one of the significant growth drivers for outsourcing such activities for cost savings and high-end expertise. Demand for personalized medicine and biologics is continuously growing and will continue to drive this trend. This trend further followed the increasing demand for personalized medicine and biologics.

Many biopharma and biotechnology companies have extended their partnership with CROs for bioanalytical services, which has accelerated biological drug development. This recent surge in outsourcing reflects the strategic shift to streamline operations and meets the rising demand for innovative therapies. For instance, in May 2024, BioAgilytix Labs, LLC, and BBI Solutions OEM Limited partnered to streamline bioanalytical testing. This partnership aligns reagent development with assay creation, making testing easier for pharma and biopharma sponsors. This streamlined approach accelerates the market entry of innovative therapies.

North America Holds Major Market Share

North America dominates the bioanalytical testing services market because of innovation and strong infrastructure. The region has well-established and developed facilities. In particular, the United States has many pharmaceutical and biotechnology companies, which creates a high demand for bioanalytical testing services. Also, strict FDA regulations in the region ensure that pharmaceutical companies maintain high-quality testing standards, which demand bioanalytical testing services. Thus, major companies are expanding their testing service portfolios to meet the increasing demand. In August 2024, SGS Societe Generale de Surveillance SA launched its new bioanalytical testing services in North America with the help of Agilex Biolabs Pty Ltd. This expansion provides more extensive, high-quality testing solutions and enhances market growth through comprehensive support for clinical trials and drug development.

Moreover, the growing need for advanced testing methods, such as immunoassays and electrophoresis, will further drive the market growth in the region. The region's strength is further emphasized due to its significant R&D investment and focus on new and innovative biopharmaceutical drug development, which enables it to set the pace of excellence in bioanalytical testing.

Future Market Scenario (2025-2032F)

The bioanalytical testing services market is anticipated to grow with the rise of R&D expenditure, biopharmaceutical industry expansion, technological advancements, severe regulatory compliance, and outsourcing trends that increase demand during the forecast period.

Strategic collaborations between pharmaceutical companies and CROs will expand the scope of high-end bioanalytical testing solutions to address varied pharmaceutical and biopharma requirements and present new growth opportunities. For example, in October 2024, Synexa Life Sciences BV enhanced its bio-analysis capabilities by acquiring Alderley Analytical Ltd. The acquisition strengthens Synexa's growth strategy and enhances its biomarker and bioanalytical assay capability, including DNA, RNA, protein, cell, and tissue analysis.

Additionally, key players are expanding their services to invest more in the advancements that support market expansion. In September 2024, Laboratory Corporation of America Holdings expanded its molecular bioanalytical laboratory in Indiana. The expansion enhanced LabCorp's global capacity to deliver advanced therapies more quickly to patients. Expanding bioanalytical capabilities supports biopharmaceutical companies, which drives future market growth and accelerates the availability of life-saving treatments.

Key Players Landscape and Outlook

Market players aim to grow by expanding services and adopting new technologies. They enter into strategic partnerships, mergers, and acquisitions to improve their offerings and benefit from the technology available to enhance their global market position.

In October 2024, Eurofins Scientific SE acquired clinical diagnostics operations for the German company SYNLAB International GmbH in Spain. The deal increases the company's commitment to delivering the best testing services worldwide. Eurofins Scientific SE considers itself the trusted, sophisticated partner of private and public sectors involved in health services, private hospitals, and insurance companies, ensuring excellent testing facilities.

In January 2024, Frontage Laboratories, Inc. expanded its European footprint by acquiring the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (part of an NMS Group S.p.A). The acquisition is one of the most significant steps forward for the company from its base in Italy, focusing on providing the best quality and cutting-edge services to clients.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bioanalytical Testing Services Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Test Type
  - 4.2.1.1. Pharmacokinetic Testing
  - 4.2.1.2. Pharmacodynamic Testing
  - 4.2.1.3. Biomarker Testing
  - 4.2.1.4. Virology Testing
  - 4.2.1.5. Serology testing
  - 4.2.1.6. Cell-based Assays
  - 4.2.1.7. Other Test Types
- 4.2.2. By Molecule
  - 4.2.2.1. Small Molecule
  - 4.2.2.2. Large Molecule
- 4.2.3. By Application
  - 4.2.3.1. Oncology
  - 4.2.3.2. Neurology
  - 4.2.3.3. Cardiology
  - 4.2.3.4. Infectious Diseases
  - 4.2.3.5. Others
- 4.2.4. By End-user
  - 4.2.4.1. Pharmaceutical and Biotechnology Companies
  - 4.2.4.2. Contract Research Organizations (CROs)
  - 4.2.4.3. Research & Academic Institutes
  - 4.2.4.4. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Test Type
- 4.3.2. By Molecule
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Bioanalytical Testing Services Market Outlook, 2018-2032F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Test Type
  - 5.2.1.1. Pharmacokinetic Testing
  - 5.2.1.2. Pharmacodynamic Testing
  - 5.2.1.3. Biomarker Testing
  - 5.2.1.4. Virology Testing
  - 5.2.1.5. Serology testing
  - 5.2.1.6. Cell-based Assays
  - 5.2.1.7. Other Test Types
- 5.2.2. By Molecule
  - 5.2.2.1. Small Molecule
  - 5.2.2.2. Large Molecule
- 5.2.3. By Application
  - 5.2.3.1. Oncology
  - 5.2.3.2. Neurology
  - 5.2.3.3. Cardiology
  - 5.2.3.4. Infectious Diseases
  - 5.2.3.5. Others
- 5.2.4. By End-user
  - 5.2.4.1. Pharmaceutical and Biotechnology Companies
  - 5.2.4.2. Contract Research Organizations (CROs)
  - 5.2.4.3. Research & Academic Institutes
  - 5.2.4.4. Others
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Bioanalytical Testing Services Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Test Type
      - 5.3.1.2.1.1. Pharmacokinetic Testing
      - 5.3.1.2.1.2. Pharmacodynamic Testing
      - 5.3.1.2.1.3. Biomarker Testing
      - 5.3.1.2.1.4. Virology Testing
      - 5.3.1.2.1.5. Serology testing
      - 5.3.1.2.1.6. Cell-based Assays
      - 5.3.1.2.1.7. Other Test Types
    - 5.3.1.2.2. By Molecule
      - 5.3.1.2.2.1. Small Molecule
      - 5.3.1.2.2.2. Large Molecule
    - 5.3.1.2.3. By Application
      - 5.3.1.2.3.1. Oncology
      - 5.3.1.2.3.2. Neurology
      - 5.3.1.2.3.3. Cardiology
      - 5.3.1.2.3.4. Infectious Diseases
      - 5.3.1.2.3.5. Others
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Pharmaceutical and Biotechnology Companies
      - 5.3.1.2.4.2. Contract Research Organizations (CROs)
      - 5.3.1.2.4.3. Research & Academic Institutes
      - 5.3.1.2.4.4. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Bioanalytical Testing Services Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Poland

7. Asia-Pacific Bioanalytical Testing Services Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Bioanalytical Testing Services Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Bioanalytical Testing Services Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa
9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. WuXi AppTec Co., Ltd.
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. Eurofins Scientific SE
- 21.3.3. Charles River Laboratories International, Inc.
- 21.3.4. ICON Plc
- 21.3.5. Thermo Fisher Scientific Inc.
- 21.3.6. Laboratory Corporation of America Holdings
- 21.3.7. SGS Societe Generale de Surveillance SA
- 21.3.8. Intertek Group plc
- 21.3.9. Frontage Laboratories, Inc.
- 21.3.10. BioAgilytix Labs, LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

バイオ分析検査サービス市場の評価：検査タイプ・分子・用途・エンドユーザー・地域別の機会および予測 (2018-2032年)

Bioanalytical Testing Services Market Assessment, By Test Type, By Molecule, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のバイオ分析検査サービス市場の展望

第5章 北米のバイオ分析検査サービス市場の展望

第6章 欧州のバイオ分析検査サービス市場の展望

第7章 アジア太平洋のバイオ分析検査サービス市場の展望

第8章 南米のバイオ分析検査サービス市場の展望

第9章 中東・アフリカのバイオ分析検査サービス市場の展望

第10章 需給分析

第11章 輸出入分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向・展開

第18章 規制の枠組みとイノベーション

第19章 特許の情勢

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的提言

第23章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bioanalytical Testing Services Market Outlook, 2018-2032F

5. North America Bioanalytical Testing Services Market Outlook, 2018-2032F*

6. Europe Bioanalytical Testing Services Market Outlook, 2018-2032F

7. Asia-Pacific Bioanalytical Testing Services Market Outlook, 2018-2032F

8. South America Bioanalytical Testing Services Market Outlook, 2018-2032F

9. Middle East and Africa Bioanalytical Testing Services Market Outlook, 2018-2032F

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界のバイオ分析検査サービス市場の展望

第5章北米のバイオ分析検査サービス市場の展望

第6章欧州のバイオ分析検査サービス市場の展望

第7章アジア太平洋のバイオ分析検査サービス市場の展望

第8章南米のバイオ分析検査サービス市場の展望

第9章中東・アフリカのバイオ分析検査サービス市場の展望

第10章需給分析

第11章輸出入分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第15章価格分析

第16章市場力学

第17章市場の動向・展開

第18章規制の枠組みとイノベーション

第19章特許の情勢

第20章ケーススタディ

第21章競合情勢

第22章戦略的提言

第23章当社について・免責事項